EDGAR·FLOW

MADRIGAL PHARMACEUTICALS, INC. — Form 4

Filed November 6, 2026 · analyzed by the Insider Agent
4 ▲ Likely positive significance 78/100
What the filing says
Director BAKER BROS. ADVISORS LP (MDGL) bought 92K shares (~$35.0M) on the open market (4.3% of holdings). Open-market insider purchase — historically a bullish signal.
Why this rating

Open-market insider purchase — historically a bullish signal.

Tradability signal
NO TRADE

No trade: only ~$0k traded in the last 30 min — too illiquid to enter and exit. (Filing arrived outside market hours — evaluated at the next open with a live quote.)

Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.

Price action (we called it positive)
before filing · preread
$399.93 ▼ 1.74%
at our read · unknown
$407.00
+10 min · unknown
$405.13 ▼ 0.46%
+30 min · unknown
$417.98 ▲ 2.70%
+1 hr · unknown
$425.27 ▲ 4.49%
+4 hrs · unknown
$428.51 ▲ 5.29%

The stock had already moved +1.77% between hitting EDGAR and our read finishing — deltas above are measured from our read.

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ MDGL · stock on Yahoo Finance ↗

See more from November 6, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.